nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—Dinoprost Tromethamine—HPGDS—liver cancer	0.0678	1	CrCbGaD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA4—liver cancer	0.0657	0.172	CbGpPWpGaD
Latanoprost—SLCO2B1—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.0414	0.109	CbGpPWpGaD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA5—liver cancer	0.0377	0.099	CbGpPWpGaD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA2—liver cancer	0.0345	0.0906	CbGpPWpGaD
Latanoprost—Embolism—Sorafenib—liver cancer	0.0342	0.0621	CcSEcCtD
Latanoprost—Hepatic function abnormal—Sorafenib—liver cancer	0.0183	0.0331	CcSEcCtD
Latanoprost—Eczema—Sorafenib—liver cancer	0.0178	0.0322	CcSEcCtD
Latanoprost—SLCO2B1—Transport of organic anions—ALB—liver cancer	0.0171	0.0448	CbGpPWpGaD
Latanoprost—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.0144	0.0261	CcSEcCtD
Latanoprost—Embolism—Epirubicin—liver cancer	0.0127	0.0229	CcSEcCtD
Latanoprost—Keratitis—Epirubicin—liver cancer	0.0125	0.0227	CcSEcCtD
Latanoprost—Embolism—Doxorubicin—liver cancer	0.0117	0.0212	CcSEcCtD
Latanoprost—Keratitis—Doxorubicin—liver cancer	0.0116	0.021	CcSEcCtD
Latanoprost—Dermatitis atopic—Epirubicin—liver cancer	0.011	0.0199	CcSEcCtD
Latanoprost—Connective tissue disorder—Sorafenib—liver cancer	0.0108	0.0197	CcSEcCtD
Latanoprost—Dermatitis atopic—Doxorubicin—liver cancer	0.0102	0.0184	CcSEcCtD
Latanoprost—Stinging—Epirubicin—liver cancer	0.01	0.0182	CcSEcCtD
Latanoprost—Mediastinal disorder—Sorafenib—liver cancer	0.00995	0.018	CcSEcCtD
Latanoprost—Erythema—Sorafenib—liver cancer	0.00961	0.0174	CcSEcCtD
Latanoprost—Stinging—Doxorubicin—liver cancer	0.00928	0.0168	CcSEcCtD
Latanoprost—Lacrimation increased—Epirubicin—liver cancer	0.00881	0.016	CcSEcCtD
Latanoprost—Inflammation—Epirubicin—liver cancer	0.00837	0.0152	CcSEcCtD
Latanoprost—Arthralgia—Sorafenib—liver cancer	0.00818	0.0148	CcSEcCtD
Latanoprost—Lacrimation increased—Doxorubicin—liver cancer	0.00815	0.0148	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00812	0.0147	CcSEcCtD
Latanoprost—Inflammation—Doxorubicin—liver cancer	0.00775	0.0141	CcSEcCtD
Latanoprost—Nervous system disorder—Sorafenib—liver cancer	0.00769	0.0139	CcSEcCtD
Latanoprost—Skin disorder—Sorafenib—liver cancer	0.00762	0.0138	CcSEcCtD
Latanoprost—Dry eye—Epirubicin—liver cancer	0.0075	0.0136	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00714	0.013	CcSEcCtD
Latanoprost—Dyspnoea—Sorafenib—liver cancer	0.00699	0.0127	CcSEcCtD
Latanoprost—Dry eye—Doxorubicin—liver cancer	0.00694	0.0126	CcSEcCtD
Latanoprost—Hepatic function abnormal—Epirubicin—liver cancer	0.00675	0.0122	CcSEcCtD
Latanoprost—Pain—Sorafenib—liver cancer	0.0067	0.0122	CcSEcCtD
Latanoprost—Eczema—Epirubicin—liver cancer	0.00656	0.0119	CcSEcCtD
Latanoprost—Eye pain—Epirubicin—liver cancer	0.00653	0.0118	CcSEcCtD
Latanoprost—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—liver cancer	0.00633	0.0166	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—TRIO—liver cancer	0.00631	0.0166	CbGpPWpGaD
Latanoprost—Hepatic function abnormal—Doxorubicin—liver cancer	0.00624	0.0113	CcSEcCtD
Latanoprost—Eczema—Doxorubicin—liver cancer	0.00607	0.011	CcSEcCtD
Latanoprost—Eye pain—Doxorubicin—liver cancer	0.00604	0.011	CcSEcCtD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.0059	0.0155	CbGpPWpGaD
Latanoprost—Diplopia—Epirubicin—liver cancer	0.0059	0.0107	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00586	0.0154	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00586	0.0154	CbGpPWpGaD
Latanoprost—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00582	0.0153	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRIO—liver cancer	0.00564	0.0148	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00563	0.0148	CbGpPWpGaD
Latanoprost—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00555	0.0146	CbGpPWpGaD
Latanoprost—Pruritus—Sorafenib—liver cancer	0.00555	0.0101	CcSEcCtD
Latanoprost—Diplopia—Doxorubicin—liver cancer	0.00545	0.00989	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00531	0.00963	CcSEcCtD
Latanoprost—Dizziness—Sorafenib—liver cancer	0.00518	0.0094	CcSEcCtD
Latanoprost—Asthma—Epirubicin—liver cancer	0.0051	0.00924	CcSEcCtD
Latanoprost—Angina pectoris—Epirubicin—liver cancer	0.00496	0.009	CcSEcCtD
Latanoprost—Rash—Sorafenib—liver cancer	0.00494	0.00897	CcSEcCtD
Latanoprost—Dermatitis—Sorafenib—liver cancer	0.00494	0.00896	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00491	0.00891	CcSEcCtD
Latanoprost—Headache—Sorafenib—liver cancer	0.00491	0.00891	CcSEcCtD
Latanoprost—Bronchitis—Epirubicin—liver cancer	0.0049	0.00889	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Epirubicin—liver cancer	0.00474	0.00859	CcSEcCtD
Latanoprost—Asthma—Doxorubicin—liver cancer	0.00471	0.00855	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.00467	0.0123	CbGpPWpGaD
Latanoprost—Angina pectoris—Doxorubicin—liver cancer	0.00459	0.00833	CcSEcCtD
Latanoprost—Bronchitis—Doxorubicin—liver cancer	0.00453	0.00822	CcSEcCtD
Latanoprost—Conjunctivitis—Epirubicin—liver cancer	0.00442	0.00801	CcSEcCtD
Latanoprost—Urinary tract infection—Epirubicin—liver cancer	0.00442	0.00801	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00438	0.00795	CcSEcCtD
Latanoprost—Urinary tract infection—Doxorubicin—liver cancer	0.00409	0.00741	CcSEcCtD
Latanoprost—Conjunctivitis—Doxorubicin—liver cancer	0.00409	0.00741	CcSEcCtD
Latanoprost—Connective tissue disorder—Epirubicin—liver cancer	0.00401	0.00727	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.00401	0.0105	CbGpPWpGaD
Latanoprost—Connective tissue disorder—Doxorubicin—liver cancer	0.00371	0.00673	CcSEcCtD
Latanoprost—Mediastinal disorder—Epirubicin—liver cancer	0.00368	0.00667	CcSEcCtD
Latanoprost—Erythema—Epirubicin—liver cancer	0.00355	0.00644	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—PRKCE—liver cancer	0.00348	0.00914	CbGpPWpGaD
Latanoprost—Back pain—Epirubicin—liver cancer	0.00343	0.00623	CcSEcCtD
Latanoprost—Mediastinal disorder—Doxorubicin—liver cancer	0.0034	0.00617	CcSEcCtD
Latanoprost—Vision blurred—Epirubicin—liver cancer	0.00335	0.00607	CcSEcCtD
Latanoprost—Erythema—Doxorubicin—liver cancer	0.00329	0.00596	CcSEcCtD
Latanoprost—Back pain—Doxorubicin—liver cancer	0.00318	0.00576	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCE—liver cancer	0.00311	0.00818	CbGpPWpGaD
Latanoprost—Vision blurred—Doxorubicin—liver cancer	0.0031	0.00562	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—CCR4—liver cancer	0.00305	0.00801	CbGpPWpGaD
Latanoprost—Arthralgia—Epirubicin—liver cancer	0.00302	0.00548	CcSEcCtD
Latanoprost—Chest pain—Epirubicin—liver cancer	0.00302	0.00548	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.003	0.00544	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.003	0.00788	CbGpPWpGaD
Latanoprost—Discomfort—Epirubicin—liver cancer	0.00299	0.00542	CcSEcCtD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—GLUL—liver cancer	0.00293	0.00769	CbGpPWpGaD
Latanoprost—Oedema—Epirubicin—liver cancer	0.0029	0.00526	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00286	0.00751	CbGpPWpGaD
Latanoprost—Nervous system disorder—Epirubicin—liver cancer	0.00284	0.00515	CcSEcCtD
Latanoprost—Skin disorder—Epirubicin—liver cancer	0.00281	0.0051	CcSEcCtD
Latanoprost—Chest pain—Doxorubicin—liver cancer	0.0028	0.00507	CcSEcCtD
Latanoprost—Arthralgia—Doxorubicin—liver cancer	0.0028	0.00507	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00278	0.00504	CcSEcCtD
Latanoprost—Discomfort—Doxorubicin—liver cancer	0.00276	0.00501	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00274	0.0072	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00274	0.0072	CbGpPWpGaD
Latanoprost—Oedema—Doxorubicin—liver cancer	0.00268	0.00486	CcSEcCtD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00265	0.00695	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00264	0.00479	CcSEcCtD
Latanoprost—Nervous system disorder—Doxorubicin—liver cancer	0.00263	0.00477	CcSEcCtD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00263	0.0069	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00263	0.0069	CbGpPWpGaD
Latanoprost—Skin disorder—Doxorubicin—liver cancer	0.0026	0.00472	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00259	0.00681	CbGpPWpGaD
Latanoprost—Dyspnoea—Epirubicin—liver cancer	0.00258	0.00469	CcSEcCtD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00252	0.00663	CbGpPWpGaD
Latanoprost—Pain—Epirubicin—liver cancer	0.00248	0.00449	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00244	0.00443	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—F2—liver cancer	0.00242	0.00635	CbGpPWpGaD
Latanoprost—Dyspnoea—Doxorubicin—liver cancer	0.00239	0.00434	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—CHN2—liver cancer	0.00232	0.0061	CbGpPWpGaD
Latanoprost—Pain—Doxorubicin—liver cancer	0.00229	0.00416	CcSEcCtD
Latanoprost—SLC22A1—Neuronal System—GLUL—liver cancer	0.00224	0.00589	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—liver cancer	0.00216	0.00568	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IFT88—liver cancer	0.00212	0.00558	CbGpPWpGaD
Latanoprost—Pruritus—Epirubicin—liver cancer	0.00205	0.00372	CcSEcCtD
Latanoprost—Dizziness—Epirubicin—liver cancer	0.00192	0.00348	CcSEcCtD
Latanoprost—Pruritus—Doxorubicin—liver cancer	0.0019	0.00344	CcSEcCtD
Latanoprost—Rash—Epirubicin—liver cancer	0.00183	0.00331	CcSEcCtD
Latanoprost—Dermatitis—Epirubicin—liver cancer	0.00183	0.00331	CcSEcCtD
Latanoprost—Headache—Epirubicin—liver cancer	0.00182	0.00329	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—TRIO—liver cancer	0.0018	0.00472	CbGpPWpGaD
Latanoprost—Dizziness—Doxorubicin—liver cancer	0.00177	0.00322	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—CCR4—liver cancer	0.00172	0.00453	CbGpPWpGaD
Latanoprost—Rash—Doxorubicin—liver cancer	0.00169	0.00307	CcSEcCtD
Latanoprost—Dermatitis—Doxorubicin—liver cancer	0.00169	0.00306	CcSEcCtD
Latanoprost—Headache—Doxorubicin—liver cancer	0.00168	0.00305	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—TRIO—liver cancer	0.00163	0.00429	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.00162	0.00426	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.0016	0.0042	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCR4—liver cancer	0.00157	0.00411	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—ALB—liver cancer	0.00136	0.00357	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00134	0.00353	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—CYCS—liver cancer	0.00132	0.00347	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SHC3—liver cancer	0.0013	0.00342	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00128	0.00337	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00123	0.00323	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00123	0.00323	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—F2—liver cancer	0.00122	0.0032	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00116	0.00305	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.00115	0.00302	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—PIK3CA—liver cancer	0.00108	0.00284	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.00105	0.00276	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FST—liver cancer	0.00101	0.00265	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PRKCE—liver cancer	0.000992	0.00261	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.000966	0.00254	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TRIO—liver cancer	0.000964	0.00253	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—UGDH—liver cancer	0.000932	0.00245	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000929	0.00244	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCR4—liver cancer	0.000925	0.00243	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PRKCE—liver cancer	0.000901	0.00237	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000894	0.00235	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CSF2—liver cancer	0.000878	0.00231	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—EPT1—liver cancer	0.000876	0.0023	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000856	0.00225	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TAT—liver cancer	0.000831	0.00218	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—BRAF—liver cancer	0.000813	0.00214	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CSF2—liver cancer	0.000797	0.00209	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADAM17—liver cancer	0.000731	0.00192	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ALB—liver cancer	0.00069	0.00181	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—F2—liver cancer	0.000689	0.00181	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PSMA4—liver cancer	0.000687	0.0018	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PSMD10—liver cancer	0.000687	0.0018	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000679	0.00178	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CG—liver cancer	0.000659	0.00173	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—F2—liver cancer	0.000626	0.00164	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000624	0.00164	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—BRAF—liver cancer	0.000623	0.00164	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.000609	0.0016	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CG—liver cancer	0.000599	0.00157	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000593	0.00156	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CD—liver cancer	0.00058	0.00152	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GLUL—liver cancer	0.000565	0.00148	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CPT1B—liver cancer	0.000565	0.00148	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NR1H4—liver cancer	0.000545	0.00143	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA3—liver cancer	0.000535	0.00141	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKCE—liver cancer	0.000532	0.0014	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CD—liver cancer	0.000526	0.00138	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—RAF1—liver cancer	0.00052	0.00137	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000515	0.00135	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CB—liver cancer	0.000505	0.00133	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF2—liver cancer	0.000504	0.00132	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA4—liver cancer	0.00049	0.00129	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA2—liver cancer	0.000477	0.00125	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CSF2—liver cancer	0.000471	0.00124	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—RAF1—liver cancer	0.00047	0.00123	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—H2AFX—liver cancer	0.000464	0.00122	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—IL2—liver cancer	0.000464	0.00122	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA1—liver cancer	0.00046	0.00121	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CB—liver cancer	0.000459	0.0012	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NAT2—liver cancer	0.000455	0.0012	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALDOB—liver cancer	0.000436	0.00115	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL2—liver cancer	0.000421	0.00111	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TERT—liver cancer	0.00042	0.0011	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CRABP1—liver cancer	0.000416	0.00109	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000416	0.00109	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KDR—liver cancer	0.000384	0.00101	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK14—liver cancer	0.000381	0.001	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ESR1—liver cancer	0.000374	0.000982	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—HRAS—liver cancer	0.000374	0.000982	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—F2—liver cancer	0.00037	0.00097	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HPGDS—liver cancer	0.000364	0.000956	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APC—liver cancer	0.000354	0.000929	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CG—liver cancer	0.000354	0.000929	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BRAF—liver cancer	0.000332	0.000873	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PSMD10—liver cancer	0.000324	0.000852	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PSMA4—liver cancer	0.000324	0.000852	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GOT2—liver cancer	0.000316	0.000829	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CD—liver cancer	0.000311	0.000816	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000309	0.000812	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CA—liver cancer	0.000308	0.000809	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SERPINE1—liver cancer	0.000308	0.000808	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—KRAS—liver cancer	0.000304	0.000799	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2E1—liver cancer	0.000297	0.000779	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—HRAS—liver cancer	0.000286	0.000752	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—RAF1—liver cancer	0.00028	0.000735	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CA—liver cancer	0.00028	0.000734	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RAF1—liver cancer	0.000278	0.000729	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYCS—liver cancer	0.000278	0.000729	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GGT1—liver cancer	0.000272	0.000715	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GOT1—liver cancer	0.000272	0.000715	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MTOR—liver cancer	0.000271	0.000712	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CB—liver cancer	0.000271	0.000712	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HRAS—liver cancer	0.000259	0.000679	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1B—liver cancer	0.000254	0.000668	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT1—liver cancer	0.000252	0.000661	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CASP3—liver cancer	0.000249	0.000655	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL2—liver cancer	0.000249	0.000654	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6—liver cancer	0.000248	0.00065	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTP1—liver cancer	0.000245	0.000642	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCND1—liver cancer	0.000243	0.000637	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JUN—liver cancer	0.000242	0.000636	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMOX1—liver cancer	0.000241	0.000634	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CTNNB1—liver cancer	0.00024	0.000631	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP9—liver cancer	0.000236	0.000619	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1A—liver cancer	0.000235	0.000616	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK8—liver cancer	0.000229	0.000602	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT1—liver cancer	0.000228	0.0006	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM1—liver cancer	0.000225	0.00059	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP1A1—liver cancer	0.000213	0.00056	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—liver cancer	0.000212	0.000555	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT3—liver cancer	0.000209	0.00055	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTHFR—liver cancer	0.000199	0.000522	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARA—liver cancer	0.000195	0.000512	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MYC—liver cancer	0.000195	0.000511	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFB1—liver cancer	0.000194	0.00051	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KRAS—liver cancer	0.00018	0.000472	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CG—liver cancer	0.000167	0.000438	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CA—liver cancer	0.000165	0.000434	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARG—liver cancer	0.000161	0.000423	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TP53—liver cancer	0.00016	0.00042	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HRAS—liver cancer	0.000153	0.000401	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CD—liver cancer	0.000147	0.000385	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6—liver cancer	0.000146	0.000384	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALB—liver cancer	0.000145	0.00038	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT1—liver cancer	0.000135	0.000354	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CB—liver cancer	0.000128	0.000336	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CA—liver cancer	7.8e-05	0.000205	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKT1—liver cancer	6.37e-05	0.000167	CbGpPWpGaD
